Upon ANA treatment, the average percentages of α2,3-linked SA+ BLCL decreased from 77% ± 9 to 38% ± 3 and of α

/ANA treatment reduces α2,3- and α2,6-linked SA expression in BLCL and decreases EV-D68 VP1+ cells to 2–5%